CSE CALI  |  Last $0.08  |  Change 0.01 OTC FNNZF  |  Last $0.04  |  Change -0.01

 

  • CTI is a top-ranked extraction and manufacturing enterprise that provides licensed, high quality BHO concentrates for white label manufacturing, toll processing and packaging to hand-selected brands and cultivators in California.
  • CTI has been in licensed operations since January 2018 and has won numerous first-place awards for its various cannabis concentrates.
  • CTI is near completion of relocating its licensed operations from Coachella to Palm Desert, California, where CTI expects to significantly increase efficiencies and expand capacity to an estimated annual production potential of approximately US$35m.
  • Under the Royalty Agreement (fully funded), FinCanna earns a perpetual royalty of 10% of CTI’s consolidated revenues, of which 5% is paid in cash monthly and 5% deferred until certain triggering events, subject to certain buyback options. Additionally FinCanna will be entitled to 25% to 50% of the sale proceeds of any change of control.

 

 

Subscribe for Updates